Healthcare -
Biotechnology - NASDAQ - US
$ 1.85
4.52 %
$ 3.8 M
Market Cap
0.08
P/E
ATXI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ATXI - Avenue Therapeutics, Inc.
7.53 M
LAST VALUE
31.07%
2 YEAR CAGR
59.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR